Researchers analyzed the charts of more than 2,000 adult patients discharged with community outpatient parenteral antimicrobial therapy from 2013 to 2014.
Of those patients, just five (0.73 percent) developed community onset C. difficile. All five of these patients had a recent exposure to a healthcare facility. Two of the five patients had hospital readmissions not related to the C. difficile infection, and four of the five were on concomitant acid suppressive therapy, according to the study.
Researchers indicate that hospital exposure and antimicrobial therapy are risk factors for developing C. difficile.
More articles on C. difficile:
Cubist reports positive preliminary results with C. diff drug
C. diff rates soar over 10 years
C. diff increases mortality risk in cirrhosis patients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.